Skip to main content
Advertisement

PLOS ONE

  • Publish
    • Submissions
      • Getting Started
      • Submission Guidelines
      • Figures
      • Tables
      • Supporting Information
      • LaTeX
      • What We Publish
      • Preprints
      • Revising Your Manuscript
      • Submit Now
      • Calls for Papers
    • Policies
      • Best Practices in Research Reporting
      • Human Subjects Research
      • Animal Research
      • Competing Interests
      • Disclosure of Funding Sources
      • Licenses and Copyright
      • Data Availability
      • Complementary Research
      • Materials, Software and Code Sharing
      • Ethical Publishing Practice
      • Authorship
      • Corrections, Expressions of Concern, and Retractions
    • Manuscript Review and Publication
      • Criteria for Publication
      • Editorial and Peer Review Process
      • Editor Center
      • Resources for Editors
      • Guidelines for Reviewers
      • Accepted Manuscripts
      • Comments

    Submit Your Manuscript

    Discover a faster, simpler path to publishing in a high-quality journal. PLOS ONE promises fair, rigorous peer review, broad scope, and wide readership – a perfect fit for your research every time.

    Learn More Submit Now

  • About
    • Why Publish with PLOS ONE
    • Journal Information
    • Staff Editors
    • Editorial Board
    • Section Editors
    • Advisory Groups
    • Find and Read Articles
    • Publishing Information
    • Publication Fees
    • Press and Media
    • Contact
  • Browse
  • Search
    advanced search
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Proteolytic Processing of ErbB4 in Breast Cancer

  • Maija Hollmén,

    Affiliations Medicity Research Laboratories, Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland, Turku Doctoral Programme of Biomedical Sciences, Turku, Finland

    ⨯
  • Ping Liu,

    Affiliation Department of Biophysics & Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    ⨯
  • Kari Kurppa,

    Affiliations Medicity Research Laboratories, Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland, Turku Doctoral Programme of Biomedical Sciences, Turku, Finland

    ⨯
  • Hans Wildiers,

    Affiliation Department of General Medical Oncology, University Hospital Leuven, Leuven, Belgium

    ⨯
  • Irene Reinvall,

    Affiliation Medicity Research Laboratories, Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland

    ⨯
  • Thijs Vandorpe,

    Affiliation Department of General Medical Oncology, University Hospital Leuven, Leuven, Belgium

    ⨯
  • Ann Smeets,

    Affiliation Department of Surgery, University Hospital Leuven, Leuven, Belgium

    ⨯
  • Karen Deraedt,

    Affiliation Department of Pathology, University Hospital Leuven, Leuven, Belgium

    ⨯
  • Tero Vahlberg,

    Affiliation Department of Statistics, University of Turku, Turku, Finland

    ⨯
  • Heikki Joensuu,

    Affiliation Department of Oncology, Helsinki University Hospital, Helsinki, Finland

    ⨯
  • Daniel J. Leahy,

    Affiliation Department of Biophysics & Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    ⨯
  • Patrick Schöffski,

    Affiliations Department of General Medical Oncology, University Hospital Leuven, Leuven, Belgium, Leuven Cancer Institute, Leuven, Belgium

    ⨯
  • Klaus Elenius

    * E-mail: klaus.elenius@utu.fi

    Affiliations Medicity Research Laboratories, Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland, Department of Oncology, Turku University Hospital, Turku, Finland

    ⨯

Proteolytic Processing of ErbB4 in Breast Cancer

  • Maija Hollmén, 
  • Ping Liu, 
  • Kari Kurppa, 
  • Hans Wildiers, 
  • Irene Reinvall, 
  • Thijs Vandorpe, 
  • Ann Smeets, 
  • Karen Deraedt, 
  • Tero Vahlberg, 
  • Heikki Joensuu
PLOS
x
  • Published: June 22, 2012
  • https://doi.org/10.1371/journal.pone.0039413
  • Article
  • Authors
  • Metrics
  • Comments
  • Media Coverage
Download PDF
 
  • Citation
  • XML
Print
  • Print article
  • Reprints
Share
  • RedditReddit
  • FacebookFacebook
  • LinkedInLinkedIn
  • MendeleyMendeley
  • TwitterTwitter
  • EmailEmail
  Check for updates via CrossMark
Advertisement

Subject Areas
?

For more information about PLOS Subject Areas, click here.

We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

  • Breast cancer  

    Is the Subject Area "Breast cancer" applicable to this article?

    Thanks for your feedback.

  • Cancer treatment  

    Is the Subject Area "Cancer treatment" applicable to this article?

    Thanks for your feedback.

  • Molting  

    Is the Subject Area "Molting" applicable to this article?

    Thanks for your feedback.

  • Enzyme-linked immunoassays  

    Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

    Thanks for your feedback.

  • Estradiol  

    Is the Subject Area "Estradiol" applicable to this article?

    Thanks for your feedback.

  • Crystal structure  

    Is the Subject Area "Crystal structure" applicable to this article?

    Thanks for your feedback.

  • Monoclonal antibodies  

    Is the Subject Area "Monoclonal antibodies" applicable to this article?

    Thanks for your feedback.

  • Cell binding  

    Is the Subject Area "Cell binding" applicable to this article?

    Thanks for your feedback.

  • Publications
  • PLOS Biology
  • PLOS Medicine
  • PLOS Computational Biology
  • PLOS Genetics
  • PLOS Pathogens
  • PLOS ONE
  • PLOS Neglected Tropical Diseases
  •  
  • PLOS Climate
  • PLOS Digital Health
  • PLOS Global Public Health
  • PLOS Sustainability and Transformation
  • PLOS Water
  • Home
  • Blogs
  • Collections
  • Give feedback
  • LOCKSS
  • Privacy Policy
  • Terms of Use
  • Advertise
  • Media Inquiries
  • Contact

PLOS PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in San Francisco, California, US